SHAPER: A Phase I Study of Losartan and Hypofractionated Radiation Therapy After Induction Chemotherapy for Borderline Resectable or Locally Advanced Pancreatic Cancer
The purpose of this phase I trial is to evaluate the safety and side effects of losartan and hypofractionated radiation therapy after chemotherapy in patients with borderline resectable or locally advanced pancreatic cancer.
Study ID: HCI121104
Trial Phase: Phase I
Trial Sponsor: National Cancer Institute (NCI), University of Utah
Therapies Used in This Trial: Losartan, Hypofractionated radiation therapy